XIAP and cancer: The birinapant inhibits cIAP1/2 to reactivate caspase-8, and the DEBIO1143 suppresses XIAP to reactivate caspase-9 both facilitates cancer cell apoptosis, which results in synergistic anti-tumor effects in combination with cisplatin (or carboplatin).